112 related articles for article (PubMed ID: 1989350)
1. Cyclosporine reversibly inhibits natural killer-cell activity.
Citterio F; Cauda R; Tumbarello M; Pozzetto U; Ortona L; Castagneto M
Transplant Proc; 1991 Feb; 23(1 Pt 2):976-7. PubMed ID: 1989350
[No Abstract] [Full Text] [Related]
2. The effect of long-term cyclosporine therapy on natural killer cell activity.
Versluis DJ; Metselaar HJ; Bijma AM; Vaessen LM; Wenting GJ; Weimar W
Transplant Proc; 1988 Apr; 20(2 Suppl 2):179-85. PubMed ID: 3129839
[No Abstract] [Full Text] [Related]
3. Enhancement of natural killer cell activity by interferon and interleukin-2 in human large granular lymphocytes inhibited by cyclosporine.
Ramsey KM; Dyer D; Stocks N; Djeu JY
Transplant Proc; 1984 Dec; 16(6):1628-31. PubMed ID: 6334388
[No Abstract] [Full Text] [Related]
4. Additive effect of cyclosporine and verapamil on the inhibition of activation and function of human peripheral blood mononuclear cells.
Weir MR; Peppler R; Gomolka D; Handwerger BS
Transplant Proc; 1988 Apr; 20(2 Suppl 2):240-4. PubMed ID: 2966479
[No Abstract] [Full Text] [Related]
5. Isoprenoid formation and cell-mediated immunological functions.
Linna J; Moke M; Chen HW
Adv Exp Med Biol; 1991; 288():269-78. PubMed ID: 1950737
[No Abstract] [Full Text] [Related]
6. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro activation of NK cytotoxicity with IL-2.
Ibayashi Y; Tokuda Y; Saks ER; Sarna GP; Golub SH
Prog Clin Biol Res; 1987; 244():275-85. PubMed ID: 3498954
[No Abstract] [Full Text] [Related]
8. In vivo activation of LAK cells during systemic IL-2 therapy.
Lang P; Vitté-Mony I; Farace F; Stancou R; Triebel F; Escudier B; Hercend T; Bertoglio J
Eur Cytokine Netw; 1990; 1(3):185-8. PubMed ID: 2129800
[No Abstract] [Full Text] [Related]
9. Leuprolide vs. diethylstilboestrol: effect on natural killer cells.
Ablin RJ; Gonder MJ; Bartkus JM
Anticancer Res; 1988; 8(1):73-6. PubMed ID: 3128959
[TBL] [Abstract][Full Text] [Related]
10. [Effects of anticonvulsants on cellular immunity].
Okamoto Y; Shimizu K; Tamura K; Yamada M; Matsui Y; Hayakawa T; Mogami H
No To Shinkei; 1989 Mar; 41(3):299-304. PubMed ID: 2503016
[TBL] [Abstract][Full Text] [Related]
11. The differential effects of human leukocyte pyrogen/lymphocyte-activating factor, T cell growth factor, and interferon on human natural killer activity.
Dempsey RA; Dinarello CA; Mier JW; Rosenwasser LJ; Allegretta M; Brown TE; Parkinson DR
J Immunol; 1982 Dec; 129(6):2504-10. PubMed ID: 6982930
[No Abstract] [Full Text] [Related]
12. Thrombin modulation of natural killer activity in human peripheral lymphocytes.
Naldini A; Carney DH
Cell Immunol; 1996 Aug; 172(1):35-42. PubMed ID: 8806804
[TBL] [Abstract][Full Text] [Related]
13. The use of 5-fluorouracil to enhance natural killer activity in rat bone marrow.
Cramer DV; Harnaha JB; Herberman RB
Transplant Proc; 1989 Apr; 21(2):3275-6. PubMed ID: 2785307
[No Abstract] [Full Text] [Related]
14. [The induction of lymphokine-activated killer cells: increased cytotoxicity via long-term cultivation].
Hartwig M; Körner IJ; Malz W
Arch Geschwulstforsch; 1989; 59(2):73-7. PubMed ID: 2785787
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-2 can induce suppression of human natural killer cell cytotoxicity.
Hellstrand K; Hermodsson S
Clin Exp Immunol; 1989 Sep; 77(3):410-6. PubMed ID: 2509116
[TBL] [Abstract][Full Text] [Related]
16. [Natural immunostimulants].
Nikitin AV; Navashin SM
Antibiotiki; 1983 Sep; 28(9):702-16. PubMed ID: 6357066
[No Abstract] [Full Text] [Related]
17. Loxoribine (7-allyl-8-oxoguanosine) activates natural killer cells and primes cytolytic precursor cells for activation by IL-2.
Pope BL; Chourmouzis E; Victorino L; MacIntyre JP; Capetola RJ; Lau CY
J Immunol; 1993 Sep; 151(6):3007-17. PubMed ID: 8376766
[TBL] [Abstract][Full Text] [Related]
18. Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity.
Brooks B; Rees RC
Clin Exp Immunol; 1988 Nov; 74(2):162-5. PubMed ID: 3265652
[TBL] [Abstract][Full Text] [Related]
19. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
Itoh K; Tilden AB; Balch CM
J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648
[TBL] [Abstract][Full Text] [Related]
20. Busulfan-induced suppression of natural killer cell activity.
Bhoopalam N; Price KS; Norgello H; Fried W
Exp Hematol; 1985 Dec; 13(11):1127-32. PubMed ID: 2933271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
